Akanda Corp. - stock earnings
AKAN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -5.9 million USD | 1.4 million USD |
| 2023Q1 | -9.1 million USD | 2.5 million USD |
| 2022Q3 | -4.7 million USD | 1.3 million USD |
| 2022Q1 | -2.8 million USD | 24072 USD |
| 2021Q4 | -2.8 million USD | 24072 USD |
| 2021Q3 | -4.7 million USD | 13424 USD |
| 2020Q4 | 585419 USD | 274 USD |
AKAN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 397045 USD | 2.6 million USD |
| 2021 | -9.2 million USD | 41431 USD |
| 2020 | -2.9 million USD | 2062 USD |
| 2019 | -1.9 million USD | ? USD |
AKAN
Price: $0.17
52 week price:
Earnings Per Share: -7.16 USD
P/E Ratio: -0.08
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Market Capitalization: 3.1 million